Schreiner Nicole M, Kalagara Hari, Morgan Charity J, Bryant Ayesha, Benz David L, Ness Timothy J, Kukreja Promil, Nagi Peter
Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, Birmingham, USA.
Biostatistics, University of Alabama at Birmingham, Birmingham, USA.
Cureus. 2020 Jun 28;12(6):e8893. doi: 10.7759/cureus.8893.
Objective To evaluate the post-operative outcomes of patients with obstructive sleep apnea (OSA) given intraoperative ketamine. Design: case-control study A total of 574 patients (287 received ketamine and 287 were matched controls) diagnosed with OSA and body mass index (BMI) > 30 who received general anesthesia were included in this study. Patients given intraoperative ketamine were matched (1:1) with those who did not receive ketamine for age, gender, BMI, ethnicity, anesthesia time, intraoperative fentanyl dose, ketamine dose, and surgery type. A sub-analysis was performed based on the dose of ketamine administered and also on the surgery type. Measured outcomes include post-operative pain scores, post-operative opioid requirements, respiratory status, oxygen use, and duration post-operatively. Results Intraoperative ketamine use did not decrease pain scores or post-operative opioid use when compared with the control (no intraoperative ketamine) group. Patients who received high-dose ketamine had significantly higher post-operative pain scores (p=0.048) while in the post-anesthesia care unit (PACU) and required supplemental oxygen for a longer period of time (p = 0.030), pain scores were not significant for patients who underwent orthopedic/spine procedures (p = 0.074), and high-dose ketamine group patients who underwent orthopedic/spine surgery required significantly more opioids in the PACU (p = 0.031). Among patients who received low-dose ketamine, those who underwent head, ear, nose, and throat surgery required significantly more opioids in PACU (p = 0.022). Conclusions Low-dose intraoperative ketamine did not decrease pain scores or post-operative opioid use significantly and did not improve standard respiratory recovery parameters for OSA patients after surgery. Neither low- nor high-dose ketamine demonstrated the anticipated benefits of low pain scores and reduced post-operative opioid use. These outcomes will differ depending on the surgery type and dose of ketamine used.
目的 评估术中使用氯胺酮的阻塞性睡眠呼吸暂停(OSA)患者的术后结局。
病例对照研究
本研究纳入了574例诊断为OSA且体重指数(BMI)>30并接受全身麻醉的患者(287例接受氯胺酮治疗,287例为匹配对照)。术中使用氯胺酮的患者与未使用氯胺酮的患者在年龄、性别、BMI、种族、麻醉时间、术中芬太尼剂量、氯胺酮剂量和手术类型方面进行了1:1匹配。根据氯胺酮给药剂量和手术类型进行了亚组分析。测量的结局包括术后疼痛评分、术后阿片类药物需求量、呼吸状态、氧气使用情况和术后持续时间。
结果 与对照组(术中未使用氯胺酮)相比,术中使用氯胺酮并未降低疼痛评分或术后阿片类药物的使用量。接受高剂量氯胺酮的患者在麻醉后恢复室(PACU)的术后疼痛评分显著更高(p = 0.048),且需要更长时间的补充氧气(p = 0.030),接受骨科/脊柱手术的患者疼痛评分无显著差异(p = 0.074), 接受骨科/脊柱手术的高剂量氯胺酮组患者在PACU需要显著更多的阿片类药物(p = 0.031)。在接受低剂量氯胺酮的患者中,接受头颈耳鼻喉手术的患者在PACU需要显著更多的阿片类药物(p = 0.022)。
结论 低剂量术中氯胺酮并未显著降低疼痛评分或术后阿片类药物的使用量,也未改善OSA患者术后的标准呼吸恢复参数。低剂量和高剂量氯胺酮均未显示出预期的低疼痛评分和减少术后阿片类药物使用的益处。这些结局将因手术类型和所用氯胺酮剂量的不同而有所差异。